Your browser doesn't support javascript.
loading
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Bashir, Qaiser; Milton, Denái R; Popat, Uday R; Kebriaei, Partow; Hosing, Chitra; Khouri, Issa F; Rezvani, Katayoun; Nieto, Yago; Oran, Betul; Srour, Samer A; Saini, Neeraj Y; Olson, Amanda L; Ahmed, Sairah; Al-Atrash, Gheath; Rondon, Gabriela; Konopleva, Marina Y; Champlin, Richard E; Shpall, Elizabeth J; Qazilbash, Muzaffar H; Pemmaraju, Naveen.
Afiliación
  • Bashir Q; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Popat UR; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Kebriaei P; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Hosing C; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Khouri IF; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Rezvani K; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Nieto Y; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Oran B; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Srour SA; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Saini NY; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Olson AL; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Ahmed S; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Al-Atrash G; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Rondon G; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Konopleva MY; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Champlin RE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Shpall EJ; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Qazilbash MH; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Pemmaraju N; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, USA.
Bone Marrow Transplant ; 57(1): 51-56, 2022 01.
Article en En | MEDLINE | ID: mdl-34629467

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Enfermedad Injerto contra Huésped / Trastornos Mieloproliferativos Tipo de estudio: Etiology_studies Límite: Adult / Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Enfermedad Injerto contra Huésped / Trastornos Mieloproliferativos Tipo de estudio: Etiology_studies Límite: Adult / Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido